| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SHPRH_0010000 | Intron-Exon-Intron | chr6:146243422-146273059 | chr6:145922286-145951923 | 250 nt | 0.3760 |
| hsa_SHPRH_0010400 | Exon-Exon | chr6:146243799-146247432 | chr6:145922663-145926296 | 375 nt | 0.4720 |
| hsa_SHPRH_0010500 | Exon-Exon | chr6:146243799-146248413 | chr6:145922663-145927277 | 263 nt | 0.4525 |
| hsa_SHPRH_0010600 | Exon-Exon | chr6:146243799-146254314 | chr6:145922663-145933178 | 528 nt | 0.4280 |
| hsa_SHPRH_0010700 | Exon-Exon | chr6:146243799-146263010 | chr6:145922663-145941874 | 1487 nt | 0.4573 |
| hsa_SHPRH_0010300 | Exon-Exon | chr6:146243799-146264938 | chr6:145922663-145943802 | 2153 nt | 0.4412 |
| hsa_SHPRH_0010900 | Exon-Exon | chr6:146244779-146254314 | chr6:145923643-145933178 | 143 nt | 0.3916 |
| hsa_SHPRH_0010800 | Exon-Exon | chr6:146244779-146271618 | chr6:145923643-145950482 | 2809 nt | 0.4336 |
| hsa_SHPRH_0011000 | Exon-Exon | chr6:146245875-146256299 | chr6:145924739-145935163 | 192 nt | 0.4635 |
| hsa_SHPRH_0011100 | Intron-Intron | chr6:146246315-146246639 | chr6:145925179-145925503 | 325 nt | 0.3077 |
A review of literature indicates that the circSHPRH is a tumor suppressor in brain cancer, specifically glioblastoma, where it is downregulated and its encoded SHPRH-146aa peptide inhibits glioma growth [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review of human studies indicates that the circSHPRH is downregulated in colorectal cancer tissues and is associated with metastasis and survival, while its overexpression inhibits proliferation and cell cycle progression [Lee et al. DOI:10.1016/j.biopha.2018.12.052].